Effect of ultra-marathon (308 km) race on bone metabolism and cartilage damage biomarkers

Annals of Rehabilitation Medicine

Volumn 36, Issue 1, 2012, Pages 80-87

  Shin, Kyung A ^a   Kim, Al Chan ^b   Kim, Young Joo ^c   Lee, Yoon Hee ^b   Shin, Young Oh ^d   Kim, Sang Hoon ^b   Park, Young Sik ^b   Nam, Hee Seung ^e   Kim, Taikon ^f   Kim, Hyoung Seop ^g   Park, Yongbum ^c  

^a Department of Internal Medicine   (South Korea)

^b Korea National Sport University   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Soonchunhyang University College of Medicine   (South Korea)

^e Hallym University College of Medicine   (South Korea)

^f Hanyang University College of Medicine   (South Korea)

^g National Health Insurance Corporation   (South Korea)

Author keywords

COMP; Osteocalcin; Osteoprotegerin; Ultra marathon

Indexed keywords

EID: 84861973610     PISSN: 22340645     EISSN: 22340653     Source Type: Journal    
DOI: 10.5535/arm.2012.36.1.80     Document Type: Article

References (29)

1. Kim HJ, Lee YH, Kim CK. Biomarkers of muscle and cartilage damage and infl ammation during a 200 km run. Eur J Appl Physiol 2007; 99: 443-447
2. Kersting UG, Stubendorff JJ, Schmidt MC, Brüggemman GP. Changes in knee cartilage volume and serum COMP concentration after running exercise. Osteoarthritis Cartilage 2005; 13: 925-934
3. Mündermann A, Dyrby CO, Andriacchi TP, King KB. Serum concentration of cartilage oligomeric matrix protein (COMP) is sensitive to physiological cyclic loading in healthy adults. Osteoarthritis Cartilage 2005; 13: 34-38
4. Neidhart M, Muller-Ladner U, Frey W, Bosserhoff AK, Colombani PC, Frey-Rindova P, Hummel KM, Gay RE, Hauselmann H, Gay S. Increased serum levels of noncollageneous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners. Osteoarthritis Cartilage 2000; 8: 222-229
5. Wong M, Carter DR. Articular cartilage functional histomorphology and mechanobiology: a research perspective. Bone 2003; 33: 1-13
6. Nieman DC, Henson DA, Smith LL, Utter AC, Vinci DM, Davis JM, Kaminsky DE Shute M. Cytokine changes after a marathon race. J Appl Physiol 2001; 91: 109-114
7. Nieman DC, Dumke CL, Henson DA, McAnulty SR, Gross SJ, Lind RH. Muscle damage is linked to cytokine changes following a 160-km race. Brain Behav Immun 2005; 19: 398-403
8. Suzuki K, Yamada M, Kurakake S, Okamura N, Yamada K, Liu Q, Kudoh S, Kowatari K, Nakaji S, Suga wara K. Circulating cytokines and hormones with immuno suppressive but neutrophil-priming potentials rise after endurance exercise in humans. Eur J Appl Physiol 2000; 81: 281-287
9. Eckstein F, Lemberger B, Gratzke C, Hudelmaier M, Glaser C, Englmeier KH, Reiser M. In vivo cartilage deformation after different types of activity and its dependence on physical training status. Ann Rheum Dis 2005; 64: 291-295
10. MacDougall JD, Webber CE, Martin J, Ormerod S, Chesley A, Younglai EV, Gordon CL, Blimkie CJ. Relationship among running mileage, bone density, and serum testosterone in male runners. J Appl Physiol 1992; 73: 1165-1170
11. Matsumoto T, Nakagawa S, Nishida S, Hirota R. Bone density and bone metabolic markers in active collegiate athletes: fi ndings in long-distance runners, judoists, and swimmers. Int J Sports Med 1997; 18: 408-412
12. Burrows M, Nevill AM, Bird S, Simpson D. Physiological factors associated with low bone mineral density in female endurance runners. Br J Sports Med 2003; 37: 67-71
13. De Souza MJ, Miller BE. The effect of endurance training on reproductive function in male runners. A 'volume threshold' hypothesis. Sports Med 1997; 23: 357-374
14. Rogers A, Eastell R. Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 2005; 90: 6323-6331
15. Kerschan-Schindl K, Thalmann M, Sodeck GH, Skenderi K, Matalas AL, Grampp S, Ebner C, Pietschmann P. A 246-km continuous running race causes significant changes in bone metabolism. Bone 2009; 45: 1079-1083
16. Calvo MS, Eyre DR, Gundberg CM. Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 1996; 17: 333-368
17. Franck H, Beuker F, Gurk S. The effect of physical activity on bone turnover in young adults. Exp Clin Endocrinol 1991; 98: 42-46
18. Tosch U, Sander B, Schubeus P, Eckart L, Felix R. Magnetic resonance tomographic and sonographic imaging of the ankle in marathon runners. Rofo 1991; 154: 150-154
19. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, Sommarin Y, Wendel M, Oldberg A, Heinegard D. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992; 267: 6132-6136
20. Skoumal M, Kolarz G, Klingler A. Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis. Scand J Rheumatol 2003; 32: 156-161
21. Sharif M, Kirwan JR, Elson CJ, Granell R, Clarke S. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum 2004; 50: 2479-2488
22. Schoppet M, Preissner KT, Hofbauer LC. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arterioscler Th romb Vasc Biol 2002; 22: 549-553
23. Shiraki M, Aoki C, Goto M. Bone and calcium metabolism in Werner's syndrome. Endocr J 1998; 45: 505-512
24. Lippi G, Schena F, Montagnana M, Salvagno GL, Banfi G, Guidi GC. Acute variation of osteocalcin and parathyroid hormone in athletes after running a halfmarathon. Clin Chem 2008; 54: 1093-1095
25. Malm HT, Ronni-Sivula HM, Viinikka LU, Ylikorkala OR. Marathon running accompanied by transient decreases in urinary calcium and serum osteocalcin levels. Calcif Tissue Int 1993; 52: 209-211
26. Mouzopoulos G, Stamatakos M, Tzurbakis M, Tsembeli A, Manti C, Safioleas M, Skandalakis P. Changes of bone turnover markers after marathon running over 245 km. Int J Sports Med 2007; 28: 576-579
27. Frost HM. The mechanostat: a proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. Bone Miner 1987; 2: 73-85
28. Frost HM. Bone " mass" and the " mechanostat" : a proposal. Anat Rec 1987; 219: 1-9
29. Bourrin S, Ghaemmaghami F, Vico L, Chappard D, Gharib, C, Alexandre C. Effect of a five-week swimming program on rat bone: a histomorphometric study. Calcif Tissue Int 1992; 51: 137-142